$ANAC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anacor Pharmaceuticals, Inc.. Get notifications about new insider transactions in Anacor Pharmaceuticals, Inc. for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 113.24 | 200 | 22,648 | 70,985 | 71.2 K to 71 K (-0.28 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 112.21 | 555 | 62,278 | 71,185 | 71.7 K to 71.2 K (-0.77 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 110.76 | 100 | 11,076 | 71,740 | 71.8 K to 71.7 K (-0.14 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 112.69 | 200 | 22,537 | 27,007 | 27.2 K to 27 K (-0.74 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 112.05 | 333 | 37,311 | 27,207 | 27.5 K to 27.2 K (-1.21 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 110.44 | 200 | 22,087 | 27,540 | 27.7 K to 27.5 K (-0.72 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 112.98 | 233 | 26,325 | 252,227 | 252.5 K to 252.2 K (-0.09 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 112.33 | 2,220 | 249,380 | 252,460 | 254.7 K to 252.5 K (-0.87 %) |
Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 110.97 | 80 | 8,878 | 254,680 | 254.8 K to 254.7 K (-0.03 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 5.59 | 14,000 | 78,260 | 27,661 | |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 114.99 | 100 | 11,499 | 28,747 | 28.8 K to 28.7 K (-0.35 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 113.79 | 2,896 | 329,524 | 28,847 | 31.7 K to 28.8 K (-9.12 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 113.14 | 9,430 | 1,066,944 | 31,743 | 41.2 K to 31.7 K (-22.90 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 112.06 | 1,574 | 176,379 | 41,173 | 42.7 K to 41.2 K (-3.68 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 5.59 | 14,000 | 78,260 | 42,747 | 28.7 K to 42.7 K (+48.70 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 111.25 | 900,000 | 100,125,000 | 325,535 | 1.2 M to 325.5 K (-73.44 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 21.21 | 6,000 | 127,260 | 294,000 | |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.20 | 14,000 | 72,800 | 0 | |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 118.59 | 500 | 59,294 | 254,760 | 255.3 K to 254.8 K (-0.20 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 117.60 | 8,178 | 961,744 | 255,260 | 263.4 K to 255.3 K (-3.10 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 117.04 | 10,732 | 1,256,050 | 263,438 | 274.2 K to 263.4 K (-3.91 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 115.52 | 590 | 68,159 | 274,170 | 274.8 K to 274.2 K (-0.21 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 21.21 | 6,000 | 127,260 | 274,760 | 268.8 K to 274.8 K (+2.23 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.20 | 14,000 | 72,800 | 268,760 | 254.8 K to 268.8 K (+5.50 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 117.36 | 40,000 | 4,694,400 | 33,886 | 73.9 K to 33.9 K (-54.14 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Option Exercise | M | 15.30 | 10,000 | 153,000 | 30,000 | |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 111.03 | 4,000 | 444,102 | 27,740 | 31.7 K to 27.7 K (-12.60 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 110.25 | 4,900 | 540,209 | 31,740 | 36.6 K to 31.7 K (-13.37 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 108.90 | 1,100 | 119,794 | 36,640 | 37.7 K to 36.6 K (-2.91 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Buy | M | 15.30 | 10,000 | 153,000 | 37,740 | 27.7 K to 37.7 K (+36.05 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | M | 19.96 | 20,000 | 399,200 | 81,000 | |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 108.22 | 2,730 | 295,441 | 71,840 | 74.6 K to 71.8 K (-3.66 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 107.86 | 17,270 | 1,862,651 | 74,570 | 91.8 K to 74.6 K (-18.80 %) |
Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Buy | M | 19.96 | 20,000 | 399,200 | 91,840 | 71.8 K to 91.8 K (+27.84 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | J | 0.00 | 73,092 | 0 | 73,886 | 794 to 73.9 K (+9,205.54 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | J | 0.00 | 372,982 | 0 | 1,225,535 | 1.6 M to 1.2 M (-23.33 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 103.60 | 100,295 | 10,390,562 | 1,598,517 | 1.7 M to 1.6 M (-5.90 %) |
Nov 05 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | J | 0.00 | 372,982 | 0 | 1,598,517 | 1.2 M to 1.6 M (+30.43 %) |
Nov 05 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | J | 0.00 | 1,500,000 | 0 | 1,225,535 | 2.7 M to 1.2 M (-55.04 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.20 | 16,000 | 83,200 | 14,000 | |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.11 | 4,000 | 20,440 | 0 | |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 140.64 | 1,799 | 253,006 | 254,760 | 256.6 K to 254.8 K (-0.70 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 139.83 | 16,209 | 2,266,573 | 256,559 | 272.8 K to 256.6 K (-5.94 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 139.03 | 1,992 | 276,950 | 272,768 | 274.8 K to 272.8 K (-0.72 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.20 | 16,000 | 83,200 | 274,760 | 258.8 K to 274.8 K (+6.18 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.11 | 4,000 | 20,440 | 258,760 | 254.8 K to 258.8 K (+1.57 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 5.59 | 14,000 | 78,260 | 41,661 | |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 140.70 | 1,301 | 183,045 | 28,744 | 30 K to 28.7 K (-4.33 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 139.85 | 11,199 | 1,566,157 | 30,045 | 41.2 K to 30 K (-27.15 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 139.00 | 1,500 | 208,498 | 41,244 | 42.7 K to 41.2 K (-3.51 %) |
Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 5.59 | 14,000 | 78,260 | 42,744 | 28.7 K to 42.7 K (+48.71 %) |
Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.11 | 20,000 | 102,200 | 4,000 | |
Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 139.45 | 11,575 | 1,614,076 | 254,760 | 266.3 K to 254.8 K (-4.35 %) |
Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 138.40 | 3,281 | 454,081 | 266,335 | 269.6 K to 266.3 K (-1.22 %) |
Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 137.53 | 3,489 | 479,824 | 269,616 | 273.1 K to 269.6 K (-1.28 %) |
Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 136.49 | 1,655 | 225,897 | 273,105 | 274.8 K to 273.1 K (-0.60 %) |
Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.11 | 20,000 | 102,200 | 274,760 | 254.8 K to 274.8 K (+7.85 %) |
Jun 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 6.92 | 7,661 | 53,014 | 33,239 | |
Jun 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 5.59 | 4,339 | 24,255 | 55,661 | |
Jun 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 69.05 | 7,661 | 528,986 | 28,156 | 35.8 K to 28.2 K (-21.39 %) |
Jun 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 6.92 | 7,661 | 53,014 | 35,817 | 28.2 K to 35.8 K (+27.21 %) |
Jun 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 69.05 | 4,339 | 299,604 | 28,156 | 32.5 K to 28.2 K (-13.35 %) |
Jun 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 5.59 | 4,339 | 24,255 | 32,495 | 28.2 K to 32.5 K (+15.41 %) |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | A | 69.40 | 4,403 | 305,568 | 4,403 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Grant | A | 0.00 | 853 | 0 | 853 | 0 to 853 |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 0.00 | 4,004 | 0 | 4,004 | |
Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 0.00 | 8,008 | 0 | 8,008 | |
Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 69.34 | 28,793 | 1,996,507 | 28,793 | |
Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Grant | A | 0.00 | 6,006 | 0 | 6,006 | 0 to 6 K |
Jun 02 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 71.72 | 100 | 7,172 | 7,220 | 7.3 K to 7.2 K (-1.37 %) |
Jun 02 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 70.03 | 500 | 35,016 | 7,320 | 7.8 K to 7.3 K (-6.39 %) |
May 15 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 63.73 | 8,920 | 568,472 | 17,840 | 26.8 K to 17.8 K (-33.33 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | M | 6.92 | 6,060 | 41,935 | 12,148 | |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 61.50 | 1,160 | 71,336 | 7,820 | 9 K to 7.8 K (-12.92 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 60.97 | 4,900 | 298,751 | 8,980 | 13.9 K to 9 K (-35.30 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Buy | M | 6.92 | 6,060 | 41,935 | 13,880 | 7.8 K to 13.9 K (+77.49 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | M | 12.49 | 11,387 | 142,224 | 18,613 | |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | M | 17.14 | 15,666 | 268,515 | 31,334 | |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | M | 5.59 | 14,715 | 82,257 | 10,285 | |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | M | 6.92 | 279 | 1,931 | 5,721 | |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | M | 6.96 | 13,895 | 96,709 | 15,105 | |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Sell | S | 63.76 | 6,000 | 382,551 | 7,020 | 13 K to 7 K (-46.08 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Sell | S | 63.20 | 11,387 | 719,609 | 13,020 | 24.4 K to 13 K (-46.65 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Buy | M | 12.49 | 11,387 | 142,224 | 24,407 | 13 K to 24.4 K (+87.46 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Sell | S | 63.19 | 15,666 | 989,920 | 13,020 | 28.7 K to 13 K (-54.61 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Buy | M | 17.14 | 15,666 | 268,515 | 28,686 | 13 K to 28.7 K (+120.32 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Sell | S | 62.09 | 14,715 | 913,691 | 13,020 | 27.7 K to 13 K (-53.06 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Buy | M | 5.59 | 14,715 | 82,257 | 27,735 | 13 K to 27.7 K (+113.02 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Sell | S | 62.05 | 279 | 17,313 | 13,020 | 13.3 K to 13 K (-2.10 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Buy | M | 6.92 | 279 | 1,931 | 13,299 | 13 K to 13.3 K (+2.14 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Sell | S | 62.05 | 13,895 | 862,238 | 13,020 | 26.9 K to 13 K (-51.63 %) |
May 14 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Buy | M | 6.96 | 13,895 | 96,709 | 26,915 | 13 K to 26.9 K (+106.72 %) |
May 01 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 54.14 | 500 | 27,071 | 7,820 | 8.3 K to 7.8 K (-6.01 %) |
May 01 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 52.99 | 100 | 5,299 | 8,320 | 8.4 K to 8.3 K (-1.19 %) |
May 01 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 53.61 | 3,125 | 167,531 | 27,740 | 30.9 K to 27.7 K (-10.12 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 63.85 | 9,750 | 622,582 | 253,760 | 263.5 K to 253.8 K (-3.70 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 62.68 | 3,448 | 216,137 | 263,510 | 267 K to 263.5 K (-1.29 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 61.74 | 2,100 | 129,658 | 266,958 | 269.1 K to 267 K (-0.78 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 60.46 | 2,078 | 125,632 | 269,058 | 271.1 K to 269.1 K (-0.77 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 59.79 | 7,624 | 455,835 | 271,136 | 278.8 K to 271.1 K (-2.73 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 66.31 | 900 | 59,683 | 278,760 | 279.7 K to 278.8 K (-0.32 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 65.51 | 16,267 | 1,065,597 | 279,660 | 295.9 K to 279.7 K (-5.50 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 64.69 | 7,833 | 506,696 | 295,927 | 303.8 K to 295.9 K (-2.58 %) |
Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 303,760 | 308.8 K to 303.8 K (-1.62 %) |
Apr 17 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 62.81 | 8,920 | 560,265 | 26,760 | 35.7 K to 26.8 K (-25.00 %) |
Apr 03 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 57.02 | 600 | 34,209 | 8,420 | 9 K to 8.4 K (-6.65 %) |
Mar 23 2015 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Buy | P | 52.43 | 3,000 | 157,304 | 173,000 | 170 K to 173 K (+1.76 %) |
Mar 23 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 56.07 | 37,500 | 2,102,644 | 308,760 | 346.3 K to 308.8 K (-10.83 %) |
Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 55.60 | 8,920 | 495,952 | 35,680 | 44.6 K to 35.7 K (-20.00 %) |
Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 6.92 | 12,000 | 83,040 | 40,900 | |
Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 56.76 | 4,100 | 232,711 | 28,156 | 32.3 K to 28.2 K (-12.71 %) |
Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 56.27 | 7,900 | 444,514 | 32,256 | 40.2 K to 32.3 K (-19.67 %) |
Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 6.92 | 12,000 | 83,040 | 40,156 | 28.2 K to 40.2 K (+42.62 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.55 | 48 | 362 | 13,552 | |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.25 | 4,952 | 35,902 | 0 | |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 45.00 | 48 | 2,160 | 29,087 | 29.1 K to 29.1 K (-0.16 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.55 | 48 | 362 | 29,135 | 29.1 K to 29.1 K (+0.17 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 45.00 | 4,952 | 222,840 | 29,087 | 34 K to 29.1 K (-14.55 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.25 | 4,952 | 35,902 | 34,039 | 29.1 K to 34 K (+17.02 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 44.34 | 1,154 | 51,174 | 70,603 | 71.8 K to 70.6 K (-1.61 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 43.81 | 7,846 | 343,763 | 71,757 | 79.6 K to 71.8 K (-9.86 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 44.60 | 400 | 17,841 | 44,600 | 45 K to 44.6 K (-0.89 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 43.99 | 6,475 | 284,815 | 45,000 | 51.5 K to 45 K (-12.58 %) |
Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 43.95 | 600 | 26,369 | 9,020 | 9.6 K to 9 K (-6.24 %) |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | A | 0.00 | 6,350 | 0 | 6,350 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | A | 37.81 | 24,360 | 921,052 | 24,360 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Grant | A | 0.00 | 5,865 | 0 | 28,156 | 22.3 K to 28.2 K (+26.31 %) |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Option Exercise | A | 0.00 | 6,350 | 0 | 6,350 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Option Exercise | A | 37.81 | 24,360 | 921,052 | 24,360 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Grant | A | 0.00 | 5,865 | 0 | 30,865 | 25 K to 30.9 K (+23.46 %) |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Rodriguez Carmen R | Snr VP Reg Afrs & Q ... | Grant | A | 0.00 | 5,020 | 0 | 13,020 | 8 K to 13 K (+62.75 %) |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Grant | A | 0.00 | 5,020 | 0 | 5,020 | 0 to 5 K |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Grant | A | 0.00 | 5,020 | 0 | 9,620 | 4.6 K to 9.6 K (+109.13 %) |
Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 |